NCT01092546View on ClinicalTrials.gov

Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

PHASE3TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Normal Pressure Hydrocephalus

Interventions

DRUG

[18F]Flutemetamol

All subjects will receive an IV dose of \[18F\]flutemetamol (less than 10 mg flutemetamol). The nominal activity of a single administration of \[18F\]flutemetamol will be 185 MBq.

Trial Locations (1)

08540

GE Healthcare, Princeton